Prove your health tech's real-world impact.

We build the clinical evidence, proof of impact, ROI demonstrations, and performance monitoring that turn promising technology into trusted, adopted, reimbursed care.

Close-up of a person looking down in soft light, wearing a small hoop earring

The Evidence Gap

Innovators in medtech, healthcare software, and AI-powered devices miss to generate the evidence and health economics data that patients, healthcare systems and payers need.

Health systems deploy these tools but can’t measure their impact on outcomes, operations and finances.

Payers won't reimburse without proof of value.

Investors won't commit without evidence of real-world impact.

That's why we built Augura.

The intelligence engine that gets healthcare innovation adopted.

We combine deep expertise in clinical research, machine learning and artificial intelligence with a platform that learns from every engagement. The result: faster, smarter evidence generation of proof of impact.

Strategy Optimization

Before designing a study, we analyze what's worked historically — and what makes your specific innovation different. Our risk intelligence engine combines years of regulatory data, adverse event patterns, and real-world outcomes with a forward-looking assessment of your solution's unique risk profile. We stratify risk based on clinical stakes: an AI making diagnostic decisions carries fundamentally different evidentiary requirements than one automating administrative workflows. We surface hidden opportunities, anticipate regulatory questions specific to your use case, and design studies calibrated to the actual risk your innovation presents — not a one-size-fits-all template.

Strategy Optimization

Before designing a study, we analyze what's worked historically — and what makes your specific innovation different. Our risk intelligence engine combines years of regulatory data, adverse event patterns, and real-world outcomes with a forward-looking assessment of your solution's unique risk profile. We stratify risk based on clinical stakes: an AI making diagnostic decisions carries fundamentally different evidentiary requirements than one automating administrative workflows. We surface hidden opportunities, anticipate regulatory questions specific to your use case, and design studies calibrated to the actual risk your innovation presents — not a one-size-fits-all template.

Icon

Evidence Generation

We design and run studies that prove your technology's real-world impact — prospective trials, casual retrospective analyses, and real-world evidence. For connected devices and software, we integrate directly with your data streams to build evidence that convinces patients, clinicians, satisfies procurement committees, and accelerates sales.

Icon

Evidence Generation

We design and run studies that prove your technology's real-world impact — prospective trials, casual retrospective analyses, and real-world evidence. For connected devices and software, we integrate directly with your data streams to build evidence that convinces patients, clinicians, satisfies procurement committees, and accelerates sales.

Smiling man with light brown hair and stubble, wearing a khaki shirt in natural light

Wonder how we can help you?

Let's schedule a moment to assess your specific case.

Smiling man with light brown hair and stubble, wearing a khaki shirt in natural light

Wonder how we can help you?

Let's schedule a moment to assess your specific case.

Our founders

Romain Pirracchio, MD MPH PhD
Chief Scientific Officer

Inaugural Ronald D. Miller Distinguished Professor at UCSF, Executive Vice Chair for the Department of Anesthesia and Perioperative Care at UCSF, Chief of Anesthesia at ZSGH, Associate and Statistical AI Editor at JAMA. Romain is trained as both a physician and a biostatistician (PhD in Biostatistics; MPH from Harvard), and leads a joint UCSF–UC Berkeley research lab pioneering the use of AI, machine learning, and causal inference for clinical decision support. He has authored over 240 peer-reviewed publications. Romain embodies the integration of rigorous clinical science with the advanced analytical methods that have transformed healthcare research.

Matthieu Legrand, MD PhD
Chief Medical Officer

Tenured Professor of Medicine and Director of Clinical Research in the Department of Anesthesia and Perioperative Medicine at UCSF. A world-leading expert in critical care and perioperative medicine, Matthieu has dedicated his career to generating evidence that improves patient outcomes. He has led multiple randomized controlled trials and authored over 300 peer-reviewed publications in The New England Journal of Medicine, JAMA, The Lancet, and other top-tier journals. Matthieu co-founded Augura to address a critical gap in healthcare AI: the need for comprehensive solutions that ensure both technical validation and meaningful clinical outcomes. His expertise spans clinical research methodology, biostatistics, and regulatory pathways with deep understanding of the challenges facing medtech innovators.

Francois Cottin, MBA
Chief Executive Officer

Twenty years building and scaling technology companies. Former founder, CEO, GM, BCG consultant, and Senior Director at Adobe leading enterprise go-to-market including AI/ML products. Deep experience in B2B sales cycles, enterprise procurement, and bringing complex technology to market. Francois built Augura because the evidence gap isn't a clinical problem, it's an infrastructure problem that requires a platform to solve.

Smiling man with light brown hair and stubble, wearing a khaki shirt in natural light

Want to know more about us?

Discover why we've built Augura, and what drives us.

Smiling man with light brown hair and stubble, wearing a khaki shirt in natural light

Want to know more about us?

Discover why we've built Augura, and what drives us.